Advocating for the consumer: clinical confirmation of all direct-to-consumer raw data alterations remains critical
Genet Med
.
2019 Mar;21(3):760-761.
doi: 10.1038/s41436-018-0095-4.
Epub 2018 Jun 27.
Authors
Stephany Tandy-Connor
1
,
Kate Krempely
2
,
Tina Pesaran
2
,
Holly LaDuca
2
,
Jenna Guiltinan
2
,
Brigette Tippin Davis
2
Affiliations
1
Ambry Genetics, 15 Argonaut, Aliso Viejo, CA, 92656, USA. sconnor@ambrygen.com.
2
Ambry Genetics, 15 Argonaut, Aliso Viejo, CA, 92656, USA.
PMID:
29950595
DOI:
10.1038/s41436-018-0095-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Direct-To-Consumer Screening and Testing*
Genetic Testing
Publications*